##plugins.themes.bootstrap3.article.main##

Joanna Jaskółowska Tomasz Gaszyński

Abstract

Introduction. According to the European Registry of AHF (Acute Heart Failure), cardiogenic pulmonary edema is the second most frequent, after exacerbated chronic heart failure, the AHF category. It can be difficult to quickly make the right diagnosis at the place of the call. The turbulent dynamics of pulmonary edema and the consequent short-term danger to life are prompting members of the outgoing teams to make quick decisions and use several treatments at the same time. Diagnosis of cardiogenic pulmonary edema, which is a symptom of acute left ventricular failure causing massive seepage to the alveoli and with rapid dyspnoea, cyanosis and expectorant foamy pink sputum, is usually evident, but not all characteristic clinical symptoms are present. The aim of the study. The aim of this article was to provide applicable guidelines in prehospital management of the cardiogenic pulmonary edema.
Selection of material. The search was performed in Scopus base, using the concepts of cardiogenic pulmonary oedema, acute heart failure, dyspnoea, prehospital management in years 2003-2017. Literature found in Google Scholar database was analysed for the number of citations. Literature selected in this way served as the material for the thesis.
Conclusions. The delay with which the treatment begins is the sum of the time elapsed from the appearance of ailments to calling for help and the time from the first contact with the health service to the implementation of the therapy. When treatment begins at home, patients have more than twice the chance of survival, than when the treatment starts only in the Emergency Department. Patients who have previously started treatment are hospitalized shorter (on average by 2.5 days) and have a lower risk of in-hospital death.

##plugins.themes.bootstrap3.article.details##

Section
Articles